nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—Lacosamide—epilepsy syndrome	0.325	1	CrCtD
Nateglinide—KCNJ11—epilepsy syndrome	0.0969	0.672	CbGaD
Nateglinide—Bortezomib—Lacosamide—epilepsy syndrome	0.071	0.325	CrCrCtD
Nateglinide—Lacosamide—Felbamate—epilepsy syndrome	0.0324	0.148	CrCrCtD
Nateglinide—CYP2D6—epilepsy syndrome	0.027	0.187	CbGaD
Nateglinide—Phenacemide—Felbamate—epilepsy syndrome	0.022	0.101	CrCrCtD
Nateglinide—ALB—epilepsy syndrome	0.0202	0.14	CbGaD
Nateglinide—Aspartame—Lacosamide—epilepsy syndrome	0.0186	0.0851	CrCrCtD
Nateglinide—L-Phenylalanine—Felbamate—epilepsy syndrome	0.0162	0.0742	CrCrCtD
Nateglinide—SLC16A1—Valproic Acid—epilepsy syndrome	0.016	0.0758	CbGbCtD
Nateglinide—UGT1A9—Propofol—epilepsy syndrome	0.0128	0.061	CbGbCtD
Nateglinide—Phenacemide—Lacosamide—epilepsy syndrome	0.0126	0.0577	CrCrCtD
Nateglinide—Amphetamine—Lacosamide—epilepsy syndrome	0.0122	0.056	CrCrCtD
Nateglinide—Dextroamphetamine—Lacosamide—epilepsy syndrome	0.0122	0.056	CrCrCtD
Nateglinide—Methamphetamine—Lacosamide—epilepsy syndrome	0.0119	0.0544	CrCrCtD
Nateglinide—L-Phenylalanine—Lacosamide—epilepsy syndrome	0.00932	0.0426	CrCrCtD
Nateglinide—UGT1A9—Valproic Acid—epilepsy syndrome	0.00917	0.0435	CbGbCtD
Nateglinide—ALB—Oxcarbazepine—epilepsy syndrome	0.00758	0.036	CbGbCtD
Nateglinide—ALB—Fosphenytoin—epilepsy syndrome	0.00663	0.0315	CbGbCtD
Nateglinide—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00609	0.0289	CbGbCtD
Nateglinide—ALB—Clonazepam—epilepsy syndrome	0.00599	0.0285	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0051	0.0242	CbGbCtD
Nateglinide—CYP3A7—Carbamazepine—epilepsy syndrome	0.0051	0.0242	CbGbCtD
Nateglinide—ALB—Rufinamide—epilepsy syndrome	0.00489	0.0232	CbGbCtD
Nateglinide—PTGS1—Diazepam—epilepsy syndrome	0.00483	0.0229	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00458	0.0217	CbGbCtD
Nateglinide—CYP3A7—Phenytoin—epilepsy syndrome	0.00458	0.0217	CbGbCtD
Nateglinide—SLC22A6—Acetazolamide—epilepsy syndrome	0.00447	0.0212	CbGbCtD
Nateglinide—ALB—Phenytoin—epilepsy syndrome	0.00427	0.0203	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00408	0.0194	CbGbCtD
Nateglinide—CYP3A7—Phenobarbital—epilepsy syndrome	0.00408	0.0194	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00402	0.0191	CbGbCtD
Nateglinide—CYP3A7—Midazolam—epilepsy syndrome	0.00402	0.0191	CbGbCtD
Nateglinide—ALB—Propofol—epilepsy syndrome	0.00398	0.0189	CbGbCtD
Nateglinide—CYP3A7—Diazepam—epilepsy syndrome	0.00387	0.0184	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00387	0.0184	CbGbCtD
Nateglinide—CYP3A5—Carbamazepine—epilepsy syndrome	0.00383	0.0182	CbGbCtD
Nateglinide—PTGS1—Valproic Acid—epilepsy syndrome	0.00381	0.0181	CbGbCtD
Nateglinide—CYP2C9—Trimethadione—epilepsy syndrome	0.0038	0.018	CbGbCtD
Nateglinide—ALB—Diazepam—epilepsy syndrome	0.00361	0.0171	CbGbCtD
Nateglinide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00357	0.017	CbGbCtD
Nateglinide—CYP3A5—Phenytoin—epilepsy syndrome	0.00343	0.0163	CbGbCtD
Nateglinide—SLC22A6—Valproic Acid—epilepsy syndrome	0.00334	0.0159	CbGbCtD
Nateglinide—CYP3A5—Phenobarbital—epilepsy syndrome	0.00306	0.0145	CbGbCtD
Nateglinide—CYP3A5—Midazolam—epilepsy syndrome	0.00302	0.0143	CbGbCtD
Nateglinide—CYP3A5—Diazepam—epilepsy syndrome	0.0029	0.0138	CbGbCtD
Nateglinide—CYP2C9—Carbamazepine—epilepsy syndrome	0.00257	0.0122	CbGbCtD
Nateglinide—CYP2C9—Primidone—epilepsy syndrome	0.0024	0.0114	CbGbCtD
Nateglinide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00238	0.0113	CbGbCtD
Nateglinide—CYP2C9—Phenytoin—epilepsy syndrome	0.0023	0.0109	CbGbCtD
Nateglinide—CYP3A5—Valproic Acid—epilepsy syndrome	0.00229	0.0109	CbGbCtD
Nateglinide—CYP3A4—Felbamate—epilepsy syndrome	0.00221	0.0105	CbGbCtD
Nateglinide—CYP3A4—Trimethadione—epilepsy syndrome	0.00221	0.0105	CbGbCtD
Nateglinide—CYP2C9—Propofol—epilepsy syndrome	0.00215	0.0102	CbGbCtD
Nateglinide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00208	0.00986	CbGbCtD
Nateglinide—CYP2C9—Phenobarbital—epilepsy syndrome	0.00205	0.00974	CbGbCtD
Nateglinide—CYP2D6—Propofol—epilepsy syndrome	0.00196	0.00932	CbGbCtD
Nateglinide—CYP2C9—Diazepam—epilepsy syndrome	0.00195	0.00923	CbGbCtD
Nateglinide—CYP3A4—Clonazepam—epilepsy syndrome	0.00188	0.00892	CbGbCtD
Nateglinide—CYP3A4—Clobazam—epilepsy syndrome	0.0018	0.00855	CbGbCtD
Nateglinide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00153	0.00728	CbGbCtD
Nateglinide—CYP3A4—Rufinamide—epilepsy syndrome	0.00153	0.00727	CbGbCtD
Nateglinide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00149	0.00708	CbGbCtD
Nateglinide—CYP3A4—Primidone—epilepsy syndrome	0.00139	0.00661	CbGbCtD
Nateglinide—CYP3A4—Phenytoin—epilepsy syndrome	0.00134	0.00635	CbGbCtD
Nateglinide—CYP3A4—Propofol—epilepsy syndrome	0.00125	0.00593	CbGbCtD
Nateglinide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00119	0.00566	CbGbCtD
Nateglinide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00119	0.00566	CbGbCtD
Nateglinide—CYP3A4—Midazolam—epilepsy syndrome	0.00118	0.00558	CbGbCtD
Nateglinide—CYP3A4—Diazepam—epilepsy syndrome	0.00113	0.00537	CbGbCtD
Nateglinide—CYP3A4—Zonisamide—epilepsy syndrome	0.0011	0.00524	CbGbCtD
Nateglinide—CYP3A4—Valproic Acid—epilepsy syndrome	0.000892	0.00423	CbGbCtD
Nateglinide—CYP3A4—Topiramate—epilepsy syndrome	0.000804	0.00382	CbGbCtD
Nateglinide—PPARG—forelimb—epilepsy syndrome	0.000778	0.0982	CbGeAlD
Nateglinide—ABCC8—brainstem—epilepsy syndrome	0.000239	0.0302	CbGeAlD
Nateglinide—ABCC8—forebrain—epilepsy syndrome	0.000231	0.0292	CbGeAlD
Nateglinide—Phenacemide—SCN1A—epilepsy syndrome	0.00023	0.141	CrCbGaD
Nateglinide—PTGS1—ganglion—epilepsy syndrome	0.000225	0.0284	CbGeAlD
Nateglinide—ABCC8—telencephalon—epilepsy syndrome	0.000212	0.0268	CbGeAlD
Nateglinide—Aspartame—TRPV1—epilepsy syndrome	0.000205	0.126	CrCbGaD
Nateglinide—SLC16A1—telencephalon—epilepsy syndrome	0.000193	0.0244	CbGeAlD
Nateglinide—PPARG—forebrain—epilepsy syndrome	0.000176	0.0223	CbGeAlD
Nateglinide—ABCC8—medulla oblongata—epilepsy syndrome	0.000167	0.0211	CbGeAlD
Nateglinide—ABCC4—forebrain—epilepsy syndrome	0.00016	0.0202	CbGeAlD
Nateglinide—Lacosamide—SCN9A—epilepsy syndrome	0.000159	0.098	CrCbGaD
Nateglinide—ABCC8—midbrain—epilepsy syndrome	0.000153	0.0192	CbGeAlD
Nateglinide—Lacosamide—SCN3A—epilepsy syndrome	0.000152	0.0937	CrCbGaD
Nateglinide—SLC16A1—medulla oblongata—epilepsy syndrome	0.000152	0.0192	CbGeAlD
Nateglinide—ABCC8—spinal cord—epilepsy syndrome	0.000149	0.0188	CbGeAlD
Nateglinide—Mitiglinide—KCNJ11—epilepsy syndrome	0.000148	0.091	CrCbGaD
Nateglinide—KCNJ11—head—epilepsy syndrome	0.000144	0.0181	CbGeAlD
Nateglinide—CYP2D6—hindbrain—epilepsy syndrome	0.00014	0.0177	CbGeAlD
Nateglinide—SLC16A1—midbrain—epilepsy syndrome	0.000139	0.0175	CbGeAlD
Nateglinide—KCNJ11—nervous system—epilepsy syndrome	0.000136	0.0172	CbGeAlD
Nateglinide—SLC16A1—spinal cord—epilepsy syndrome	0.000135	0.0171	CbGeAlD
Nateglinide—ABCC8—head—epilepsy syndrome	0.000132	0.0167	CbGeAlD
Nateglinide—KCNJ11—central nervous system—epilepsy syndrome	0.000131	0.0165	CbGeAlD
Nateglinide—KCNJ11—cerebellum—epilepsy syndrome	0.000128	0.0162	CbGeAlD
Nateglinide—SLC15A2—telencephalon—epilepsy syndrome	0.000127	0.016	CbGeAlD
Nateglinide—ABCC8—nervous system—epilepsy syndrome	0.000125	0.0158	CbGeAlD
Nateglinide—Enalapril—SLCO1A2—epilepsy syndrome	0.000125	0.0768	CrCbGaD
Nateglinide—ORM1—spinal cord—epilepsy syndrome	0.000122	0.0153	CbGeAlD
Nateglinide—ABCC8—central nervous system—epilepsy syndrome	0.000121	0.0152	CbGeAlD
Nateglinide—SLC16A1—head—epilepsy syndrome	0.00012	0.0152	CbGeAlD
Nateglinide—ABCC8—cerebellum—epilepsy syndrome	0.000118	0.0149	CbGeAlD
Nateglinide—SLC16A1—nervous system—epilepsy syndrome	0.000114	0.0144	CbGeAlD
Nateglinide—SLC22A6—brain—epilepsy syndrome	0.00011	0.0139	CbGeAlD
Nateglinide—SLC16A1—central nervous system—epilepsy syndrome	0.00011	0.0139	CbGeAlD
Nateglinide—SLC16A1—cerebellum—epilepsy syndrome	0.000107	0.0135	CbGeAlD
Nateglinide—L-Phenylalanine—TH—epilepsy syndrome	0.000105	0.0645	CrCbGaD
Nateglinide—KCNJ11—brain—epilepsy syndrome	0.000104	0.0131	CbGeAlD
Nateglinide—ORM1—nervous system—epilepsy syndrome	0.000102	0.0129	CbGeAlD
Nateglinide—PPARG—head—epilepsy syndrome	0.000101	0.0127	CbGeAlD
Nateglinide—Lacosamide—CA4—epilepsy syndrome	0.0001	0.0617	CrCbGaD
Nateglinide—SLC15A2—medulla oblongata—epilepsy syndrome	9.97e-05	0.0126	CbGeAlD
Nateglinide—ORM1—central nervous system—epilepsy syndrome	9.86e-05	0.0124	CbGeAlD
Nateglinide—ABCC8—brain—epilepsy syndrome	9.58e-05	0.0121	CbGeAlD
Nateglinide—PPARG—nervous system—epilepsy syndrome	9.57e-05	0.0121	CbGeAlD
Nateglinide—PTGS1—forebrain—epilepsy syndrome	9.43e-05	0.0119	CbGeAlD
Nateglinide—PPARG—central nervous system—epilepsy syndrome	9.22e-05	0.0116	CbGeAlD
Nateglinide—ABCC4—head—epilepsy syndrome	9.17e-05	0.0116	CbGeAlD
Nateglinide—SLC15A2—midbrain—epilepsy syndrome	9.12e-05	0.0115	CbGeAlD
Nateglinide—SLC15A2—spinal cord—epilepsy syndrome	8.89e-05	0.0112	CbGeAlD
Nateglinide—SLC16A1—brain—epilepsy syndrome	8.72e-05	0.011	CbGeAlD
Nateglinide—ABCC4—nervous system—epilepsy syndrome	8.69e-05	0.011	CbGeAlD
Nateglinide—PTGS1—telencephalon—epilepsy syndrome	8.67e-05	0.0109	CbGeAlD
Nateglinide—ABCC4—central nervous system—epilepsy syndrome	8.37e-05	0.0106	CbGeAlD
Nateglinide—CYP2D6—brainstem—epilepsy syndrome	8.03e-05	0.0101	CbGeAlD
Nateglinide—SLC15A2—head—epilepsy syndrome	7.9e-05	0.00998	CbGeAlD
Nateglinide—CYP2D6—forebrain—epilepsy syndrome	7.75e-05	0.00978	CbGeAlD
Nateglinide—SLC15A2—nervous system—epilepsy syndrome	7.49e-05	0.00946	CbGeAlD
Nateglinide—Ramipril—BCHE—epilepsy syndrome	7.4e-05	0.0455	CrCbGaD
Nateglinide—PPARG—brain—epilepsy syndrome	7.32e-05	0.00923	CbGeAlD
Nateglinide—SLC15A2—central nervous system—epilepsy syndrome	7.22e-05	0.00911	CbGeAlD
Nateglinide—CYP2D6—telencephalon—epilepsy syndrome	7.12e-05	0.00899	CbGeAlD
Nateglinide—SLC15A2—cerebellum—epilepsy syndrome	7.05e-05	0.0089	CbGeAlD
Nateglinide—ALB—brain—epilepsy syndrome	6.86e-05	0.00866	CbGeAlD
Nateglinide—ABCC4—brain—epilepsy syndrome	6.64e-05	0.00838	CbGeAlD
Nateglinide—Hyperhidrosis—Lamotrigine—epilepsy syndrome	6.26e-05	0.00113	CcSEcCtD
Nateglinide—Urticaria—Vigabatrin—epilepsy syndrome	6.24e-05	0.00113	CcSEcCtD
Nateglinide—Hypersensitivity—Midazolam—epilepsy syndrome	6.23e-05	0.00113	CcSEcCtD
Nateglinide—Dyspepsia—Clonazepam—epilepsy syndrome	6.22e-05	0.00113	CcSEcCtD
Nateglinide—Abdominal pain—Vigabatrin—epilepsy syndrome	6.21e-05	0.00113	CcSEcCtD
Nateglinide—Nausea—Clobazam—epilepsy syndrome	6.2e-05	0.00112	CcSEcCtD
Nateglinide—Asthenia—Propofol—epilepsy syndrome	6.2e-05	0.00112	CcSEcCtD
Nateglinide—Erythema multiforme—Pregabalin—epilepsy syndrome	6.19e-05	0.00112	CcSEcCtD
Nateglinide—Dyspepsia—Phenytoin—epilepsy syndrome	6.18e-05	0.00112	CcSEcCtD
Nateglinide—Dizziness—Acetazolamide—epilepsy syndrome	6.15e-05	0.00112	CcSEcCtD
Nateglinide—Hypersensitivity—Levetiracetam—epilepsy syndrome	6.15e-05	0.00111	CcSEcCtD
Nateglinide—Urticaria—Diazepam—epilepsy syndrome	6.15e-05	0.00111	CcSEcCtD
Nateglinide—Sweating increased—Topiramate—epilepsy syndrome	6.14e-05	0.00111	CcSEcCtD
Nateglinide—Dyspepsia—Oxcarbazepine—epilepsy syndrome	6.14e-05	0.00111	CcSEcCtD
Nateglinide—Gastrointestinal pain—Felbamate—epilepsy syndrome	6.12e-05	0.00111	CcSEcCtD
Nateglinide—Pruritus—Propofol—epilepsy syndrome	6.12e-05	0.00111	CcSEcCtD
Nateglinide—Abdominal pain—Diazepam—epilepsy syndrome	6.12e-05	0.00111	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	6.1e-05	0.0011	CcSEcCtD
Nateglinide—Back pain—Valproic Acid—epilepsy syndrome	6.1e-05	0.0011	CcSEcCtD
Nateglinide—Fatigue—Clonazepam—epilepsy syndrome	6.09e-05	0.0011	CcSEcCtD
Nateglinide—PTGS1—spinal cord—epilepsy syndrome	6.07e-05	0.00766	CbGeAlD
Nateglinide—Asthenia—Midazolam—epilepsy syndrome	6.07e-05	0.0011	CcSEcCtD
Nateglinide—Bronchitis—Topiramate—epilepsy syndrome	6.07e-05	0.0011	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	6.06e-05	0.0011	CcSEcCtD
Nateglinide—Fatigue—Phenytoin—epilepsy syndrome	6.05e-05	0.0011	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	6.02e-05	0.00109	CcSEcCtD
Nateglinide—Fatigue—Oxcarbazepine—epilepsy syndrome	6.02e-05	0.00109	CcSEcCtD
Nateglinide—Gastrointestinal pain—Zonisamide—epilepsy syndrome	5.99e-05	0.00109	CcSEcCtD
Nateglinide—Asthenia—Levetiracetam—epilepsy syndrome	5.99e-05	0.00109	CcSEcCtD
Nateglinide—Pruritus—Midazolam—epilepsy syndrome	5.98e-05	0.00108	CcSEcCtD
Nateglinide—Urticaria—Felbamate—epilepsy syndrome	5.95e-05	0.00108	CcSEcCtD
Nateglinide—Abdominal pain—Felbamate—epilepsy syndrome	5.92e-05	0.00107	CcSEcCtD
Nateglinide—Vomiting—Acetazolamide—epilepsy syndrome	5.92e-05	0.00107	CcSEcCtD
Nateglinide—Diarrhoea—Propofol—epilepsy syndrome	5.91e-05	0.00107	CcSEcCtD
Nateglinide—Oedema peripheral—Gabapentin—epilepsy syndrome	5.91e-05	0.00107	CcSEcCtD
Nateglinide—Immune system disorder—Pregabalin—epilepsy syndrome	5.91e-05	0.00107	CcSEcCtD
Nateglinide—Pruritus—Levetiracetam—epilepsy syndrome	5.91e-05	0.00107	CcSEcCtD
Nateglinide—Tremor—Valproic Acid—epilepsy syndrome	5.9e-05	0.00107	CcSEcCtD
Nateglinide—Dyspepsia—Carbamazepine—epilepsy syndrome	5.89e-05	0.00107	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Topiramate—epilepsy syndrome	5.86e-05	0.00106	CcSEcCtD
Nateglinide—Urticaria—Zonisamide—epilepsy syndrome	5.82e-05	0.00105	CcSEcCtD
Nateglinide—Abdominal pain—Zonisamide—epilepsy syndrome	5.79e-05	0.00105	CcSEcCtD
Nateglinide—Hypersensitivity—Vigabatrin—epilepsy syndrome	5.79e-05	0.00105	CcSEcCtD
Nateglinide—Asthenia—Fosphenytoin—epilepsy syndrome	5.78e-05	0.00105	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	5.78e-05	0.00105	CcSEcCtD
Nateglinide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	5.78e-05	0.00105	CcSEcCtD
Nateglinide—Fatigue—Carbamazepine—epilepsy syndrome	5.77e-05	0.00105	CcSEcCtD
Nateglinide—SLC15A2—brain—epilepsy syndrome	5.73e-05	0.00723	CbGeAlD
Nateglinide—Dizziness—Propofol—epilepsy syndrome	5.72e-05	0.00104	CcSEcCtD
Nateglinide—Diarrhoea—Levetiracetam—epilepsy syndrome	5.71e-05	0.00104	CcSEcCtD
Nateglinide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	5.71e-05	0.00103	CcSEcCtD
Nateglinide—Pruritus—Fosphenytoin—epilepsy syndrome	5.7e-05	0.00103	CcSEcCtD
Nateglinide—Hypersensitivity—Diazepam—epilepsy syndrome	5.7e-05	0.00103	CcSEcCtD
Nateglinide—Dyspepsia—Lamotrigine—epilepsy syndrome	5.7e-05	0.00103	CcSEcCtD
Nateglinide—Malnutrition—Pregabalin—epilepsy syndrome	5.7e-05	0.00103	CcSEcCtD
Nateglinide—Erythema multiforme—Gabapentin—epilepsy syndrome	5.67e-05	0.00103	CcSEcCtD
Nateglinide—Asthenia—Vigabatrin—epilepsy syndrome	5.64e-05	0.00102	CcSEcCtD
Nateglinide—Urticaria—Clonazepam—epilepsy syndrome	5.61e-05	0.00102	CcSEcCtD
Nateglinide—Dizziness—Midazolam—epilepsy syndrome	5.59e-05	0.00101	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	5.59e-05	0.00101	CcSEcCtD
Nateglinide—Abdominal pain—Clonazepam—epilepsy syndrome	5.58e-05	0.00101	CcSEcCtD
Nateglinide—Fatigue—Lamotrigine—epilepsy syndrome	5.58e-05	0.00101	CcSEcCtD
Nateglinide—Urticaria—Phenytoin—epilepsy syndrome	5.57e-05	0.00101	CcSEcCtD
Nateglinide—Palpitations—Valproic Acid—epilepsy syndrome	5.57e-05	0.00101	CcSEcCtD
Nateglinide—Pruritus—Vigabatrin—epilepsy syndrome	5.56e-05	0.00101	CcSEcCtD
Nateglinide—Asthenia—Diazepam—epilepsy syndrome	5.55e-05	0.00101	CcSEcCtD
Nateglinide—Urticaria—Oxcarbazepine—epilepsy syndrome	5.54e-05	0.001	CcSEcCtD
Nateglinide—Nausea—Acetazolamide—epilepsy syndrome	5.53e-05	0.001	CcSEcCtD
Nateglinide—Dizziness—Levetiracetam—epilepsy syndrome	5.52e-05	0.001	CcSEcCtD
Nateglinide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	5.52e-05	0.001	CcSEcCtD
Nateglinide—Bortezomib—CYP2C19—epilepsy syndrome	5.52e-05	0.0339	CrCbGaD
Nateglinide—Diarrhoea—Fosphenytoin—epilepsy syndrome	5.52e-05	0.000999	CcSEcCtD
Nateglinide—Neuropathy peripheral—Topiramate—epilepsy syndrome	5.51e-05	0.000999	CcSEcCtD
Nateglinide—Back pain—Pregabalin—epilepsy syndrome	5.51e-05	0.000999	CcSEcCtD
Nateglinide—Cough—Valproic Acid—epilepsy syndrome	5.5e-05	0.000996	CcSEcCtD
Nateglinide—Vomiting—Propofol—epilepsy syndrome	5.5e-05	0.000996	CcSEcCtD
Nateglinide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	5.48e-05	0.000992	CcSEcCtD
Nateglinide—Pruritus—Diazepam—epilepsy syndrome	5.47e-05	0.000992	CcSEcCtD
Nateglinide—Rash—Propofol—epilepsy syndrome	5.45e-05	0.000988	CcSEcCtD
Nateglinide—Dermatitis—Propofol—epilepsy syndrome	5.45e-05	0.000987	CcSEcCtD
Nateglinide—Immune system disorder—Gabapentin—epilepsy syndrome	5.42e-05	0.000982	CcSEcCtD
Nateglinide—Hypersensitivity—Zonisamide—epilepsy syndrome	5.4e-05	0.000978	CcSEcCtD
Nateglinide—PTGS1—head—epilepsy syndrome	5.4e-05	0.00681	CbGeAlD
Nateglinide—Vomiting—Midazolam—epilepsy syndrome	5.38e-05	0.000974	CcSEcCtD
Nateglinide—Diarrhoea—Vigabatrin—epilepsy syndrome	5.38e-05	0.000974	CcSEcCtD
Nateglinide—Asthenia—Felbamate—epilepsy syndrome	5.37e-05	0.000973	CcSEcCtD
Nateglinide—Tremor—Pregabalin—epilepsy syndrome	5.34e-05	0.000967	CcSEcCtD
Nateglinide—Rash—Midazolam—epilepsy syndrome	5.33e-05	0.000966	CcSEcCtD
Nateglinide—Dizziness—Fosphenytoin—epilepsy syndrome	5.33e-05	0.000966	CcSEcCtD
Nateglinide—Dermatitis—Midazolam—epilepsy syndrome	5.33e-05	0.000965	CcSEcCtD
Nateglinide—Urticaria—Carbamazepine—epilepsy syndrome	5.32e-05	0.000964	CcSEcCtD
Nateglinide—Vomiting—Levetiracetam—epilepsy syndrome	5.31e-05	0.000962	CcSEcCtD
Nateglinide—Pruritus—Felbamate—epilepsy syndrome	5.3e-05	0.00096	CcSEcCtD
Nateglinide—Abdominal pain—Carbamazepine—epilepsy syndrome	5.29e-05	0.000959	CcSEcCtD
Nateglinide—Diarrhoea—Diazepam—epilepsy syndrome	5.29e-05	0.000959	CcSEcCtD
Nateglinide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.29e-05	0.000959	CcSEcCtD
Nateglinide—Rash—Levetiracetam—epilepsy syndrome	5.27e-05	0.000954	CcSEcCtD
Nateglinide—Dermatitis—Levetiracetam—epilepsy syndrome	5.26e-05	0.000953	CcSEcCtD
Nateglinide—Asthenia—Zonisamide—epilepsy syndrome	5.26e-05	0.000953	CcSEcCtD
Nateglinide—Malnutrition—Gabapentin—epilepsy syndrome	5.22e-05	0.000947	CcSEcCtD
Nateglinide—Hypersensitivity—Clonazepam—epilepsy syndrome	5.2e-05	0.000943	CcSEcCtD
Nateglinide—Dizziness—Vigabatrin—epilepsy syndrome	5.2e-05	0.000941	CcSEcCtD
Nateglinide—Pruritus—Zonisamide—epilepsy syndrome	5.18e-05	0.000939	CcSEcCtD
Nateglinide—Hypersensitivity—Phenytoin—epilepsy syndrome	5.17e-05	0.000937	CcSEcCtD
Nateglinide—Urticaria—Lamotrigine—epilepsy syndrome	5.14e-05	0.000932	CcSEcCtD
Nateglinide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.14e-05	0.000932	CcSEcCtD
Nateglinide—Nausea—Propofol—epilepsy syndrome	5.13e-05	0.00093	CcSEcCtD
Nateglinide—Vomiting—Fosphenytoin—epilepsy syndrome	5.13e-05	0.000929	CcSEcCtD
Nateglinide—Diarrhoea—Felbamate—epilepsy syndrome	5.12e-05	0.000928	CcSEcCtD
Nateglinide—PTGS1—nervous system—epilepsy syndrome	5.12e-05	0.00646	CbGeAlD
Nateglinide—Abdominal pain—Lamotrigine—epilepsy syndrome	5.12e-05	0.000927	CcSEcCtD
Nateglinide—Dizziness—Diazepam—epilepsy syndrome	5.12e-05	0.000927	CcSEcCtD
Nateglinide—Rash—Fosphenytoin—epilepsy syndrome	5.08e-05	0.000921	CcSEcCtD
Nateglinide—Dermatitis—Fosphenytoin—epilepsy syndrome	5.08e-05	0.00092	CcSEcCtD
Nateglinide—Asthenia—Clonazepam—epilepsy syndrome	5.07e-05	0.000918	CcSEcCtD
Nateglinide—Back pain—Gabapentin—epilepsy syndrome	5.05e-05	0.000916	CcSEcCtD
Nateglinide—Palpitations—Pregabalin—epilepsy syndrome	5.03e-05	0.000912	CcSEcCtD
Nateglinide—Asthenia—Phenytoin—epilepsy syndrome	5.03e-05	0.000912	CcSEcCtD
Nateglinide—Nausea—Midazolam—epilepsy syndrome	5.02e-05	0.00091	CcSEcCtD
Nateglinide—Diarrhoea—Zonisamide—epilepsy syndrome	5.01e-05	0.000909	CcSEcCtD
Nateglinide—Asthenia—Oxcarbazepine—epilepsy syndrome	5.01e-05	0.000907	CcSEcCtD
Nateglinide—Pruritus—Clonazepam—epilepsy syndrome	5e-05	0.000905	CcSEcCtD
Nateglinide—Vomiting—Vigabatrin—epilepsy syndrome	5e-05	0.000905	CcSEcCtD
Nateglinide—Oedema peripheral—Topiramate—epilepsy syndrome	4.97e-05	0.000901	CcSEcCtD
Nateglinide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.97e-05	0.000901	CcSEcCtD
Nateglinide—Cough—Pregabalin—epilepsy syndrome	4.97e-05	0.000901	CcSEcCtD
Nateglinide—Pruritus—Phenytoin—epilepsy syndrome	4.96e-05	0.000899	CcSEcCtD
Nateglinide—Nausea—Levetiracetam—epilepsy syndrome	4.96e-05	0.000899	CcSEcCtD
Nateglinide—Rash—Vigabatrin—epilepsy syndrome	4.95e-05	0.000898	CcSEcCtD
Nateglinide—Dizziness—Felbamate—epilepsy syndrome	4.95e-05	0.000897	CcSEcCtD
Nateglinide—Dermatitis—Vigabatrin—epilepsy syndrome	4.95e-05	0.000897	CcSEcCtD
Nateglinide—Pruritus—Oxcarbazepine—epilepsy syndrome	4.94e-05	0.000895	CcSEcCtD
Nateglinide—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.93e-05	0.000894	CcSEcCtD
Nateglinide—PTGS1—central nervous system—epilepsy syndrome	4.93e-05	0.00622	CbGeAlD
Nateglinide—Vomiting—Diazepam—epilepsy syndrome	4.92e-05	0.000891	CcSEcCtD
Nateglinide—Tremor—Gabapentin—epilepsy syndrome	4.89e-05	0.000887	CcSEcCtD
Nateglinide—Rash—Diazepam—epilepsy syndrome	4.88e-05	0.000884	CcSEcCtD
Nateglinide—Dermatitis—Diazepam—epilepsy syndrome	4.87e-05	0.000883	CcSEcCtD
Nateglinide—Dizziness—Zonisamide—epilepsy syndrome	4.85e-05	0.000878	CcSEcCtD
Nateglinide—Diarrhoea—Clonazepam—epilepsy syndrome	4.83e-05	0.000876	CcSEcCtD
Nateglinide—Asthenia—Carbamazepine—epilepsy syndrome	4.8e-05	0.000871	CcSEcCtD
Nateglinide—Diarrhoea—Phenytoin—epilepsy syndrome	4.8e-05	0.00087	CcSEcCtD
Nateglinide—Nausea—Fosphenytoin—epilepsy syndrome	4.79e-05	0.000868	CcSEcCtD
Nateglinide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.77e-05	0.000865	CcSEcCtD
Nateglinide—Erythema multiforme—Topiramate—epilepsy syndrome	4.77e-05	0.000865	CcSEcCtD
Nateglinide—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.77e-05	0.000864	CcSEcCtD
Nateglinide—Vomiting—Felbamate—epilepsy syndrome	4.76e-05	0.000863	CcSEcCtD
Nateglinide—Pruritus—Carbamazepine—epilepsy syndrome	4.74e-05	0.000858	CcSEcCtD
Nateglinide—Rash—Felbamate—epilepsy syndrome	4.72e-05	0.000855	CcSEcCtD
Nateglinide—Dermatitis—Felbamate—epilepsy syndrome	4.72e-05	0.000855	CcSEcCtD
Nateglinide—Dizziness—Clonazepam—epilepsy syndrome	4.67e-05	0.000846	CcSEcCtD
Nateglinide—Nausea—Vigabatrin—epilepsy syndrome	4.67e-05	0.000846	CcSEcCtD
Nateglinide—Vomiting—Zonisamide—epilepsy syndrome	4.66e-05	0.000844	CcSEcCtD
Nateglinide—Asthenia—Lamotrigine—epilepsy syndrome	4.64e-05	0.000841	CcSEcCtD
Nateglinide—Dizziness—Phenytoin—epilepsy syndrome	4.64e-05	0.000841	CcSEcCtD
Nateglinide—Rash—Zonisamide—epilepsy syndrome	4.62e-05	0.000837	CcSEcCtD
Nateglinide—Palpitations—Gabapentin—epilepsy syndrome	4.62e-05	0.000836	CcSEcCtD
Nateglinide—Dermatitis—Zonisamide—epilepsy syndrome	4.62e-05	0.000836	CcSEcCtD
Nateglinide—Dizziness—Oxcarbazepine—epilepsy syndrome	4.61e-05	0.000836	CcSEcCtD
Nateglinide—Nausea—Diazepam—epilepsy syndrome	4.59e-05	0.000833	CcSEcCtD
Nateglinide—Diarrhoea—Carbamazepine—epilepsy syndrome	4.58e-05	0.00083	CcSEcCtD
Nateglinide—Pruritus—Lamotrigine—epilepsy syndrome	4.58e-05	0.00083	CcSEcCtD
Nateglinide—Immune system disorder—Topiramate—epilepsy syndrome	4.56e-05	0.000826	CcSEcCtD
Nateglinide—Cough—Gabapentin—epilepsy syndrome	4.56e-05	0.000826	CcSEcCtD
Nateglinide—Dyspepsia—Valproic Acid—epilepsy syndrome	4.53e-05	0.00082	CcSEcCtD
Nateglinide—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.49e-05	0.000814	CcSEcCtD
Nateglinide—Vomiting—Clonazepam—epilepsy syndrome	4.49e-05	0.000814	CcSEcCtD
Nateglinide—Vomiting—Phenytoin—epilepsy syndrome	4.46e-05	0.000808	CcSEcCtD
Nateglinide—Rash—Clonazepam—epilepsy syndrome	4.45e-05	0.000807	CcSEcCtD
Nateglinide—Dermatitis—Clonazepam—epilepsy syndrome	4.45e-05	0.000806	CcSEcCtD
Nateglinide—Nausea—Felbamate—epilepsy syndrome	4.45e-05	0.000806	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.44e-05	0.000805	CcSEcCtD
Nateglinide—Vomiting—Oxcarbazepine—epilepsy syndrome	4.44e-05	0.000804	CcSEcCtD
Nateglinide—CYP2D6—head—epilepsy syndrome	4.44e-05	0.0056	CbGeAlD
Nateglinide—Fatigue—Valproic Acid—epilepsy syndrome	4.43e-05	0.000803	CcSEcCtD
Nateglinide—Dizziness—Carbamazepine—epilepsy syndrome	4.43e-05	0.000802	CcSEcCtD
Nateglinide—Diarrhoea—Lamotrigine—epilepsy syndrome	4.43e-05	0.000802	CcSEcCtD
Nateglinide—Rash—Phenytoin—epilepsy syndrome	4.42e-05	0.000802	CcSEcCtD
Nateglinide—Dermatitis—Phenytoin—epilepsy syndrome	4.42e-05	0.000801	CcSEcCtD
Nateglinide—Rash—Oxcarbazepine—epilepsy syndrome	4.4e-05	0.000797	CcSEcCtD
Nateglinide—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.4e-05	0.000797	CcSEcCtD
Nateglinide—Malnutrition—Topiramate—epilepsy syndrome	4.4e-05	0.000796	CcSEcCtD
Nateglinide—Nausea—Zonisamide—epilepsy syndrome	4.35e-05	0.000789	CcSEcCtD
Nateglinide—Dizziness—Lamotrigine—epilepsy syndrome	4.28e-05	0.000775	CcSEcCtD
Nateglinide—CYP3A4—nervous system—epilepsy syndrome	4.27e-05	0.00539	CbGeAlD
Nateglinide—Vomiting—Carbamazepine—epilepsy syndrome	4.26e-05	0.000772	CcSEcCtD
Nateglinide—Back pain—Topiramate—epilepsy syndrome	4.25e-05	0.00077	CcSEcCtD
Nateglinide—Rash—Carbamazepine—epilepsy syndrome	4.22e-05	0.000765	CcSEcCtD
Nateglinide—Dermatitis—Carbamazepine—epilepsy syndrome	4.22e-05	0.000764	CcSEcCtD
Nateglinide—CYP2D6—nervous system—epilepsy syndrome	4.21e-05	0.00531	CbGeAlD
Nateglinide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.21e-05	0.000762	CcSEcCtD
Nateglinide—Nausea—Clonazepam—epilepsy syndrome	4.2e-05	0.00076	CcSEcCtD
Nateglinide—Nausea—Phenytoin—epilepsy syndrome	4.17e-05	0.000755	CcSEcCtD
Nateglinide—Nausea—Oxcarbazepine—epilepsy syndrome	4.15e-05	0.000751	CcSEcCtD
Nateglinide—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.12e-05	0.000747	CcSEcCtD
Nateglinide—Tremor—Topiramate—epilepsy syndrome	4.12e-05	0.000746	CcSEcCtD
Nateglinide—Vomiting—Lamotrigine—epilepsy syndrome	4.12e-05	0.000746	CcSEcCtD
Nateglinide—CYP3A4—central nervous system—epilepsy syndrome	4.12e-05	0.00519	CbGeAlD
Nateglinide—Bortezomib—CYP2D6—epilepsy syndrome	4.09e-05	0.0252	CrCbGaD
Nateglinide—Urticaria—Valproic Acid—epilepsy syndrome	4.09e-05	0.00074	CcSEcCtD
Nateglinide—Rash—Lamotrigine—epilepsy syndrome	4.08e-05	0.000739	CcSEcCtD
Nateglinide—Dermatitis—Lamotrigine—epilepsy syndrome	4.08e-05	0.000739	CcSEcCtD
Nateglinide—Abdominal pain—Valproic Acid—epilepsy syndrome	4.07e-05	0.000737	CcSEcCtD
Nateglinide—CYP2D6—central nervous system—epilepsy syndrome	4.05e-05	0.00511	CbGeAlD
Nateglinide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.01e-05	0.000727	CcSEcCtD
Nateglinide—Fatigue—Pregabalin—epilepsy syndrome	4.01e-05	0.000726	CcSEcCtD
Nateglinide—Nausea—Carbamazepine—epilepsy syndrome	3.98e-05	0.000721	CcSEcCtD
Nateglinide—CYP2D6—cerebellum—epilepsy syndrome	3.96e-05	0.00499	CbGeAlD
Nateglinide—PTGS1—brain—epilepsy syndrome	3.91e-05	0.00494	CbGeAlD
Nateglinide—Palpitations—Topiramate—epilepsy syndrome	3.88e-05	0.000704	CcSEcCtD
Nateglinide—Nausea—Lamotrigine—epilepsy syndrome	3.84e-05	0.000697	CcSEcCtD
Nateglinide—Cough—Topiramate—epilepsy syndrome	3.84e-05	0.000695	CcSEcCtD
Nateglinide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.8e-05	0.000689	CcSEcCtD
Nateglinide—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.79e-05	0.000687	CcSEcCtD
Nateglinide—Dyspepsia—Gabapentin—epilepsy syndrome	3.75e-05	0.00068	CcSEcCtD
Nateglinide—Urticaria—Pregabalin—epilepsy syndrome	3.69e-05	0.000669	CcSEcCtD
Nateglinide—Asthenia—Valproic Acid—epilepsy syndrome	3.69e-05	0.000669	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.68e-05	0.000667	CcSEcCtD
Nateglinide—Fatigue—Gabapentin—epilepsy syndrome	3.68e-05	0.000666	CcSEcCtD
Nateglinide—Abdominal pain—Pregabalin—epilepsy syndrome	3.68e-05	0.000666	CcSEcCtD
Nateglinide—Pruritus—Valproic Acid—epilepsy syndrome	3.64e-05	0.000659	CcSEcCtD
Nateglinide—Diarrhoea—Valproic Acid—epilepsy syndrome	3.52e-05	0.000638	CcSEcCtD
Nateglinide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.49e-05	0.000632	CcSEcCtD
Nateglinide—Hyperhidrosis—Topiramate—epilepsy syndrome	3.47e-05	0.000628	CcSEcCtD
Nateglinide—Hypersensitivity—Pregabalin—epilepsy syndrome	3.43e-05	0.000621	CcSEcCtD
Nateglinide—Dizziness—Valproic Acid—epilepsy syndrome	3.4e-05	0.000616	CcSEcCtD
Nateglinide—Urticaria—Gabapentin—epilepsy syndrome	3.39e-05	0.000614	CcSEcCtD
Nateglinide—Methamphetamine—ADRA2A—epilepsy syndrome	3.37e-05	0.0208	CrCbGaD
Nateglinide—Abdominal pain—Gabapentin—epilepsy syndrome	3.37e-05	0.000611	CcSEcCtD
Nateglinide—Asthenia—Pregabalin—epilepsy syndrome	3.34e-05	0.000604	CcSEcCtD
Nateglinide—Pruritus—Pregabalin—epilepsy syndrome	3.29e-05	0.000596	CcSEcCtD
Nateglinide—Vomiting—Valproic Acid—epilepsy syndrome	3.27e-05	0.000593	CcSEcCtD
Nateglinide—Rash—Valproic Acid—epilepsy syndrome	3.24e-05	0.000588	CcSEcCtD
Nateglinide—Dermatitis—Valproic Acid—epilepsy syndrome	3.24e-05	0.000587	CcSEcCtD
Nateglinide—CYP2D6—brain—epilepsy syndrome	3.21e-05	0.00406	CbGeAlD
Nateglinide—Diarrhoea—Pregabalin—epilepsy syndrome	3.18e-05	0.000576	CcSEcCtD
Nateglinide—Dyspepsia—Topiramate—epilepsy syndrome	3.16e-05	0.000572	CcSEcCtD
Nateglinide—Hypersensitivity—Gabapentin—epilepsy syndrome	3.14e-05	0.000569	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.1e-05	0.000561	CcSEcCtD
Nateglinide—Fatigue—Topiramate—epilepsy syndrome	3.09e-05	0.00056	CcSEcCtD
Nateglinide—Dizziness—Pregabalin—epilepsy syndrome	3.07e-05	0.000557	CcSEcCtD
Nateglinide—Asthenia—Gabapentin—epilepsy syndrome	3.06e-05	0.000554	CcSEcCtD
Nateglinide—Nausea—Valproic Acid—epilepsy syndrome	3.05e-05	0.000554	CcSEcCtD
Nateglinide—Pruritus—Gabapentin—epilepsy syndrome	3.02e-05	0.000547	CcSEcCtD
Nateglinide—Lisinopril—ABCB1—epilepsy syndrome	2.99e-05	0.0184	CrCbGaD
Nateglinide—Cilazapril—ABCB1—epilepsy syndrome	2.99e-05	0.0184	CrCbGaD
Nateglinide—Vomiting—Pregabalin—epilepsy syndrome	2.96e-05	0.000536	CcSEcCtD
Nateglinide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.93e-05	0.000531	CcSEcCtD
Nateglinide—Rash—Pregabalin—epilepsy syndrome	2.93e-05	0.000531	CcSEcCtD
Nateglinide—Dermatitis—Pregabalin—epilepsy syndrome	2.93e-05	0.000531	CcSEcCtD
Nateglinide—Diarrhoea—Gabapentin—epilepsy syndrome	2.92e-05	0.000529	CcSEcCtD
Nateglinide—Urticaria—Topiramate—epilepsy syndrome	2.85e-05	0.000516	CcSEcCtD
Nateglinide—Abdominal pain—Topiramate—epilepsy syndrome	2.84e-05	0.000514	CcSEcCtD
Nateglinide—Dizziness—Gabapentin—epilepsy syndrome	2.82e-05	0.000511	CcSEcCtD
Nateglinide—Amphetamine—SLC6A4—epilepsy syndrome	2.78e-05	0.0171	CrCbGaD
Nateglinide—Nausea—Pregabalin—epilepsy syndrome	2.76e-05	0.0005	CcSEcCtD
Nateglinide—Vomiting—Gabapentin—epilepsy syndrome	2.71e-05	0.000491	CcSEcCtD
Nateglinide—Rash—Gabapentin—epilepsy syndrome	2.69e-05	0.000487	CcSEcCtD
Nateglinide—Dermatitis—Gabapentin—epilepsy syndrome	2.69e-05	0.000487	CcSEcCtD
Nateglinide—Hypersensitivity—Topiramate—epilepsy syndrome	2.64e-05	0.000479	CcSEcCtD
Nateglinide—Methamphetamine—SLC6A4—epilepsy syndrome	2.57e-05	0.0158	CrCbGaD
Nateglinide—Asthenia—Topiramate—epilepsy syndrome	2.57e-05	0.000466	CcSEcCtD
Nateglinide—Pruritus—Topiramate—epilepsy syndrome	2.54e-05	0.00046	CcSEcCtD
Nateglinide—Nausea—Gabapentin—epilepsy syndrome	2.53e-05	0.000459	CcSEcCtD
Nateglinide—Diarrhoea—Topiramate—epilepsy syndrome	2.45e-05	0.000445	CcSEcCtD
Nateglinide—Dextroamphetamine—CYP2D6—epilepsy syndrome	2.42e-05	0.0149	CrCbGaD
Nateglinide—Dizziness—Topiramate—epilepsy syndrome	2.37e-05	0.00043	CcSEcCtD
Nateglinide—Vomiting—Topiramate—epilepsy syndrome	2.28e-05	0.000413	CcSEcCtD
Nateglinide—Rash—Topiramate—epilepsy syndrome	2.26e-05	0.00041	CcSEcCtD
Nateglinide—Dermatitis—Topiramate—epilepsy syndrome	2.26e-05	0.000409	CcSEcCtD
Nateglinide—Enalapril—ABCB1—epilepsy syndrome	2.2e-05	0.0135	CrCbGaD
Nateglinide—Nausea—Topiramate—epilepsy syndrome	2.13e-05	0.000386	CcSEcCtD
Nateglinide—Amphetamine—CYP2D6—epilepsy syndrome	1.95e-05	0.012	CrCbGaD
Nateglinide—Methamphetamine—CYP2D6—epilepsy syndrome	1.81e-05	0.0111	CrCbGaD
Nateglinide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.23e-06	6.02e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—HMOX1—epilepsy syndrome	2.21e-06	5.97e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	2.2e-06	5.94e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CAT—epilepsy syndrome	2.18e-06	5.89e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	2.18e-06	5.88e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	2.18e-06	5.88e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	2.18e-06	5.88e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—YWHAZ—epilepsy syndrome	2.15e-06	5.8e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	2.14e-06	5.8e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	2.14e-06	5.78e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	2.14e-06	5.78e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TXNRD1—epilepsy syndrome	2.13e-06	5.77e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	2.12e-06	5.73e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	2.12e-06	5.73e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.12e-06	5.73e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ABCB1—epilepsy syndrome	2.12e-06	5.73e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.1e-06	5.68e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.08e-06	5.64e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	2.08e-06	5.62e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AQP1—epilepsy syndrome	2.07e-06	5.6e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CA4—epilepsy syndrome	2.07e-06	5.6e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	2.07e-06	5.6e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	2.06e-06	5.58e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	2.04e-06	5.52e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	2.04e-06	5.52e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	2.04e-06	5.52e-05	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.04e-06	5.5e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—BCHE—epilepsy syndrome	2.03e-06	5.5e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—POMC—epilepsy syndrome	2.03e-06	5.48e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	2.02e-06	5.47e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	2.02e-06	5.47e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	2.02e-06	5.46e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	2e-06	5.4e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.99e-06	5.38e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.98e-06	5.35e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	1.98e-06	5.35e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—BCHE—epilepsy syndrome	1.97e-06	5.33e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GPX1—epilepsy syndrome	1.97e-06	5.32e-05	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TNF—epilepsy syndrome	1.97e-06	5.32e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—POMC—epilepsy syndrome	1.97e-06	5.32e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.97e-06	5.32e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.96e-06	5.29e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.95e-06	5.26e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.94e-06	5.25e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	1.94e-06	5.24e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—POMC—epilepsy syndrome	1.94e-06	5.24e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.92e-06	5.19e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	1.92e-06	5.19e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—AKT1—epilepsy syndrome	1.92e-06	5.18e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TH—epilepsy syndrome	1.91e-06	5.17e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PLAU—epilepsy syndrome	1.9e-06	5.15e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.9e-06	5.14e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	1.9e-06	5.13e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.88e-06	5.09e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	1.88e-06	5.08e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.87e-06	5.07e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CHRM3—epilepsy syndrome	1.87e-06	5.07e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CAT—epilepsy syndrome	1.87e-06	5.06e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.87e-06	5.05e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PLCB1—epilepsy syndrome	1.86e-06	5.03e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TH—epilepsy syndrome	1.85e-06	5.01e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ALB—epilepsy syndrome	1.85e-06	5e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.85e-06	4.99e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.85e-06	4.99e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.85e-06	4.99e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.85e-06	4.99e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.85e-06	4.99e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.82e-06	4.93e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	1.82e-06	4.92e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ALB—epilepsy syndrome	1.79e-06	4.85e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	1.77e-06	4.79e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.77e-06	4.79e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ALB—epilepsy syndrome	1.77e-06	4.78e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.76e-06	4.76e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NOS2—epilepsy syndrome	1.75e-06	4.73e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.75e-06	4.72e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.74e-06	4.72e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	1.73e-06	4.67e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AGT—epilepsy syndrome	1.73e-06	4.67e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	1.72e-06	4.64e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.71e-06	4.62e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.71e-06	4.62e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.7e-06	4.58e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GPX1—epilepsy syndrome	1.69e-06	4.58e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—APOE—epilepsy syndrome	1.69e-06	4.57e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.69e-06	4.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.69e-06	4.56e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.69e-06	4.56e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.63e-06	4.4e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.63e-06	4.39e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—epilepsy syndrome	1.62e-06	4.37e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	1.6e-06	4.31e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CAT—epilepsy syndrome	1.57e-06	4.26e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.57e-06	4.24e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.57e-06	4.24e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—epilepsy syndrome	1.57e-06	4.24e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	1.55e-06	4.19e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.55e-06	4.18e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.55e-06	4.18e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—HMOX1—epilepsy syndrome	1.55e-06	4.18e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—epilepsy syndrome	1.55e-06	4.18e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.53e-06	4.15e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.53e-06	4.15e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	1.53e-06	4.14e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCG2—epilepsy syndrome	1.53e-06	4.13e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CAT—epilepsy syndrome	1.53e-06	4.12e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.49e-06	4.02e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AGT—epilepsy syndrome	1.48e-06	4.01e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ABCB1—epilepsy syndrome	1.48e-06	4.01e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.48e-06	4e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.48e-06	3.99e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.48e-06	3.99e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.47e-06	3.97e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.47e-06	3.97e-05	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—epilepsy syndrome	1.47e-06	3.96e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—APOE—epilepsy syndrome	1.45e-06	3.93e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—POMC—epilepsy syndrome	1.45e-06	3.93e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.44e-06	3.88e-05	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—epilepsy syndrome	1.43e-06	3.86e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.43e-06	3.86e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GPX1—epilepsy syndrome	1.42e-06	3.85e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.4e-06	3.79e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.4e-06	3.78e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.4e-06	3.78e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.4e-06	3.78e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.39e-06	3.75e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TH—epilepsy syndrome	1.38e-06	3.74e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GPX1—epilepsy syndrome	1.38e-06	3.73e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.34e-06	3.61e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.33e-06	3.61e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.33e-06	3.61e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—epilepsy syndrome	1.33e-06	3.58e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.31e-06	3.53e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.28e-06	3.46e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.27e-06	3.44e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—BCHE—epilepsy syndrome	1.27e-06	3.42e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.26e-06	3.41e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.25e-06	3.39e-05	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.25e-06	3.39e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.25e-06	3.38e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—POMC—epilepsy syndrome	1.25e-06	3.38e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.25e-06	3.37e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.23e-06	3.33e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.23e-06	3.32e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.22e-06	3.31e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.22e-06	3.3e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.22e-06	3.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.21e-06	3.27e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AGT—epilepsy syndrome	1.21e-06	3.27e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.21e-06	3.26e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.2e-06	3.25e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PLCB1—epilepsy syndrome	1.19e-06	3.23e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TH—epilepsy syndrome	1.19e-06	3.22e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOE—epilepsy syndrome	1.19e-06	3.2e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.17e-06	3.17e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—epilepsy syndrome	1.16e-06	3.13e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.15e-06	3.12e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.15e-06	3.11e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—epilepsy syndrome	1.14e-06	3.08e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.14e-06	3.08e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.12e-06	3.02e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.11e-06	2.99e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.1e-06	2.96e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.09e-06	2.95e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.05e-06	2.84e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.05e-06	2.84e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.04e-06	2.83e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SRC—epilepsy syndrome	1.04e-06	2.81e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.04e-06	2.81e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.04e-06	2.8e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.03e-06	2.78e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—POMC—epilepsy syndrome	1.02e-06	2.75e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.01e-06	2.74e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.01e-06	2.73e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.01e-06	2.73e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	9.97e-07	2.69e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	9.96e-07	2.69e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMOX1—epilepsy syndrome	9.93e-07	2.68e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	9.88e-07	2.67e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	9.86e-07	2.67e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TH—epilepsy syndrome	9.82e-07	2.66e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAT—epilepsy syndrome	9.8e-07	2.65e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	9.77e-07	2.64e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TH—epilepsy syndrome	9.74e-07	2.63e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.59e-07	2.59e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—epilepsy syndrome	9.58e-07	2.59e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCB1—epilepsy syndrome	9.53e-07	2.58e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—epilepsy syndrome	9.28e-07	2.51e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AGT—epilepsy syndrome	9.02e-07	2.44e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPX1—epilepsy syndrome	8.86e-07	2.4e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOE—epilepsy syndrome	8.84e-07	2.39e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	8.38e-07	2.27e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	8.24e-07	2.23e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	8.2e-07	2.22e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—epilepsy syndrome	8.13e-07	2.2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	8.13e-07	2.2e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—epilepsy syndrome	8.12e-07	2.2e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAT—epilepsy syndrome	8.09e-07	2.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	8.03e-07	2.17e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAT—epilepsy syndrome	8.02e-07	2.17e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.99e-07	2.16e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—epilepsy syndrome	7.89e-07	2.13e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	7.87e-07	2.13e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	7.8e-07	2.11e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—epilepsy syndrome	7.77e-07	2.1e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AGT—epilepsy syndrome	7.77e-07	2.1e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOE—epilepsy syndrome	7.61e-07	2.06e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—POMC—epilepsy syndrome	7.59e-07	2.05e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—epilepsy syndrome	7.49e-07	2.03e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	7.32e-07	1.98e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	7.25e-07	1.96e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	7.21e-07	1.95e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—epilepsy syndrome	6.92e-07	1.87e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.86e-07	1.85e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.83e-07	1.85e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—POMC—epilepsy syndrome	6.54e-07	1.77e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.52e-07	1.76e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—epilepsy syndrome	6.47e-07	1.75e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.45e-07	1.74e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TH—epilepsy syndrome	6.42e-07	1.74e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AGT—epilepsy syndrome	6.42e-07	1.73e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AGT—epilepsy syndrome	6.36e-07	1.72e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOE—epilepsy syndrome	6.29e-07	1.7e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOE—epilepsy syndrome	6.23e-07	1.68e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	6.06e-07	1.64e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—epilepsy syndrome	5.83e-07	1.58e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.4e-07	1.46e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.36e-07	1.45e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—POMC—epilepsy syndrome	5.35e-07	1.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAT—epilepsy syndrome	5.29e-07	1.43e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—epilepsy syndrome	5.22e-07	1.41e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.15e-07	1.39e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—epilepsy syndrome	5.01e-07	1.35e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.92e-07	1.33e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—epilepsy syndrome	4.88e-07	1.32e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.78e-07	1.29e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.31e-07	1.16e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	4.27e-07	1.15e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—epilepsy syndrome	4.21e-07	1.14e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.19e-07	1.13e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.11e-07	1.11e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—epilepsy syndrome	4.08e-07	1.1e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.53e-07	9.55e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.22e-07	8.7e-06	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.04e-07	8.23e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.82e-07	7.61e-06	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—epilepsy syndrome	2.62e-07	7.09e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.16e-07	5.85e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.15e-07	5.8e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.42e-07	3.83e-06	CbGpPWpGaD
